ENDO HEALTH SOLUTIONS, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 3rd, 2014 • Endo Health Solutions Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is hereby entered into as of May 24, 2013, by and between Endo Health Solutions, Inc. (the “Company”) and Donald DeGolyer (“Executive”) (hereinafter collectively referred to as “the parties”).
FOURTH SUPPLEMENTAL INDENTUREFourth Supplemental Indenture • March 3rd, 2014 • Endo Health Solutions Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionFOURTH SUPPLEMENTAL INDENTURE (this “Fourth Supplemental Indenture”), dated as of December 2, 2013, among Endo Health Solutions Inc. (formerly known as Endo Pharmaceuticals Holdings Inc.), a Delaware corporation (the “Company”), the Guarantors (as such term is defined in the Indenture) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).
FOURTH SUPPLEMENTAL INDENTURESupplemental Indenture • March 3rd, 2014 • Endo Health Solutions Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionFOURTH SUPPLEMENTAL INDENTURE (this “Fourth Supplemental Indenture”), dated as of December 2, 2013, among Endo Health Solutions Inc. (formerly known as Endo Pharmaceuticals Holdings Inc.), a Delaware corporation (the “Company”), the Guarantors (as such term is defined in the Indenture) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).
ContractDevelopment, Licence and Supply Agreement • March 3rd, 2014 • Endo Health Solutions Inc. • Pharmaceutical preparations
Contract Type FiledMarch 3rd, 2014 Company IndustryThe confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***.
STOCK PURCHASE AGREEMENT dated as of January 8, 2014 by and among HT INTERMEDIATE COMPANY, LLC, and ENDO HEALTH SOLUTIONS INC.Stock Purchase Agreement • March 3rd, 2014 • Endo Health Solutions Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”), dated as of January 8, 2014, is entered into by and among HT Intermediate Company, LLC, a Delaware limited liability company (“Buyer”), and Endo Health Solutions Inc., a Delaware corporation (the “Seller”).
EIGHTH SUPPLEMENTAL INDENTUREEighth Supplemental Indenture • March 3rd, 2014 • Endo Health Solutions Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 3rd, 2014 Company Industry JurisdictionEIGHTH SUPPLEMENTAL INDENTURE (this “Eighth Supplemental Indenture”), dated as of December 2, 2013, among Endo Health Solutions Inc. (formerly known as Endo Pharmaceuticals Holdings Inc.), a Delaware corporation (the “Company”), the Guarantors (as such term is defined in the Indenture) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).